Avid Bioservices Inc (CDMO)

[entdoc]

here's the point: does a rational patient or physician consider a "Bavituximab" product on the basis of safety? No contest. Does a rational patient and oncologist consider using MAB Bavituximab targeted on an exclusive cancer cell docking site which is loaded with a cytotoxic agent du jeur sprinkled with a quantum of naked Bavi? It makes a great deal of sense to me.